EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

OMIP‐119 : A 36‐Color Full‐Spectrum Flow Cytometry Panel for Deep Immunophenotyping of Peripheral Blood and Ex Vivo Expanded Human T Cells

Robert J Harris iD, Benjamin Arkle, Elizabeth Evans, Charles H V Smith, Rebecca Teevan, Natalie Bath

Cytometry Part A · 2025-12 · 107 (12) · 787-792

DOI: 10.1002/cytoa.70001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytometry Part A, online erschienen am 12.12.2025. Verfasst von Robert J Harris und 5 weiteren Autor:innen. Beteiligte Einrichtung: Adaptimmune Ltd, Abingdon, Oxfordshire, UK. Hauptthemen laut MEDLINE: Immunophenotyping, Flow Cytometry, T-Lymphocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing uptake of adoptive CAR‐T and TCR‐T cell therapies into clinical practice has intensified the need for robust and detailed immunophenotyping of ex vivo expanded T cells. We have developed and optimized an extended 36‐color full‐spectrum flow cytometry panel suitable for in‐depth immunophenotyping of both peripheral blood and ex vivo expanded human T cells. Our panel allows for analysis of CD4 + and CD8 + memory subpopulations (Tn/Tscm, Tcm, Tem, and Temra), Treg subsets (CD45RA + and CD39 + ), and helper T cell subsets (Tfh, Th1, Th2, and Th17). Intracellular staining facilitates the evaluation of functional markers granzyme B (cytotoxicity) and Ki‐67 (proliferation). Our panel allows detailed investigation of T cell activation using markers carrying a range of expression kinetics. Exhaustion and senescence features, known to correlate with resistance to immunotherapies, can also be thoroughly evaluated. TCR staining with pHLA‐dextramer or anti‐TCR antibody is also included to allow evaluation of TCR specificity and/or transduction efficiency. A PD‐1 receptor occupancy component enables quantification of T cells bound to antibodies from immune checkpoint inhibitor (ICI) therapies. Overall, we have generated a fully optimized and fit‐for‐purpose extended T cell profiling panel with particular relevance to the field of immunotherapies including ICIs and adoptive T cell therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunophenotypingFlow CytometryT-LymphocytesHumansLymphocyte ActivationT-Lymphocyte SubsetsCD8-Positive T-LymphocytesCD4-Positive T-Lymphocytes

Autor:innen und Institutionen

  • Adaptimmune Ltd, Abingdon, Oxfordshire, UK.

ORCID-Profile: Robert J Harris

Zitieren

APA

Harris, R. J., Arkle, B., Evans, E., Smith, C. H. V., Teevan, R., & Bath, N. (2025). OMIP‐119 : A 36‐Color Full‐Spectrum Flow Cytometry Panel for Deep Immunophenotyping of Peripheral Blood and Ex Vivo Expanded Human T Cells. Cytometry Part A, 107(12), 787-792. https://doi.org/10.1002/cytoa.70001

Vancouver

Harris RJ, Arkle B, Evans E, Smith CHV, Teevan R, Bath N. OMIP‐119 : A 36‐Color Full‐Spectrum Flow Cytometry Panel for Deep Immunophenotyping of Peripheral Blood and Ex Vivo Expanded Human T Cells. Cytometry Part A. 2025;107(12):787-792. doi:10.1002/cytoa.70001

BibTeX
@article{Harris2025,
  author = {Harris, Robert J and Arkle, Benjamin and Evans, Elizabeth and Smith, Charles H V and Teevan, Rebecca and Bath, Natalie},
  title = {OMIP‐119 : A 36‐Color Full‐Spectrum Flow Cytometry Panel for Deep Immunophenotyping of Peripheral Blood and Ex Vivo Expanded Human T Cells},
  journal = {Cytometry Part A},
  year = {2025},
  volume = {107},
  number = {12},
  pages = {787--792},
  doi = {10.1002/cytoa.70001}
}
Kostenlos starten →